ArticleInternational journal of chronic obstructive pulmonary disease2026
Opinion and Knowledge of Pulmonologists, Primary Care Physicians, and Nurses About Inhaled Therapy in COPD. Inhal-Epoc Survey.
Article in International journal of chronic obstructive pulmonary disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Despite the efforts made to improve inhalation technique by both patients and healthcare professionals, significant deficiencies were found in critical aspects of inhaler use and device selection. The aim of this study is to know the current opinion and knowledge of pulmonologists, primary care physicians, and nurses about inhaled therapy in chronic obstructive pulmonary disease (COPD). Methods: Survey conducted between April-July 2023 by a committee of experts formed by 2 pulmonologists, 2 primary care physicians, and one nurse specialist in inhaled therapy. It consisted of 27 questions and was sent by e-mail to professionals throughout Spain with experience in the management of COPD with inhaled therapy. Results: A total of 554 experts from all over Spain participated. Thirty-one percent and 43.5% of the respondents could not identify, respectively, which were the critical steps for correct inhalation of the pressurized metered-dose inhaler (pMDI) and the multidose dry powder inhaler (DPI). Conventional pMDIs were considered to be the devices that provide greater oropharyngeal deposition and less pulmonary deposition. The majority of respondents considered essential or important to take into account the patients' opinion in selecting the inhaler, and preferred to review the inhalation technique rather than change the device. The main criteria for the choice of inhaler in COPD patients were their previous experience, preference, and severity. With a wide dispersion of results, Ellypta®, pMDI with chamber, Genuair®, Respimat®, and conventional pMDI were preferred in that order. Conclusion: Knowledge about inhaled therapy in COPD remains insufficient. There is a significant and important lack of knowledge in key aspects of the use of inhaler devices, such as the critical steps for correct inhalation and the selection criteria for inhalation devices. It is necessary to continue promoting training programs for both patients and healthcare personnel in inhalers and inhalation techniques.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.